Position in LNTH
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$36,028
+$4,417 QoQ
Shares Held
475
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BELLEVUE ASSET MANAGEMENT, LLC holds $110,337 across 3 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (32.7% of the industry book) .
All Filings in LNTH
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,028 | 475 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $31,611 | 475 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $24,362 | 475 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $38,883 | 475 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $46,360 | 475 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $42,493 | 475 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $52,131 | 475 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $38,137 | 475 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $29,564 | 475 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $29,450 | 475 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $33,003 | 475 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $39,862 | 475 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $39,216 | 475 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $24,206 | 475 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $33,406 | 475 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $31,364 | 475 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,272 | 475 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $13,722 | 475 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $12,198 | 475 | Shares | Sole | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||